Lee P, Sun Y, Soares A, Fai C, Picciotto M, Guo J
Mol Cell. 2024; 84(20):3967-3978.e8.
PMID: 39317199
PMC: 11490368.
DOI: 10.1016/j.molcel.2024.08.032.
St Peter C, Hossain W, Lovell S, Rafi S, Butler M
Int J Mol Sci. 2024; 25(5).
PMID: 38474085
PMC: 10932183.
DOI: 10.3390/ijms25052838.
Lee P, Soares A, Sun Y, Fai C, Picciotto M, Guo J
bioRxiv. 2024; .
PMID: 38405936
PMC: 10888845.
DOI: 10.1101/2024.02.16.580719.
Lu Y, Zhu Q, Wang Y, Luo M, Huang J, Liang Q
Haematologica. 2024; 109(9):2955-2968.
PMID: 38385251
PMC: 11367199.
DOI: 10.3324/haematol.2023.284183.
Xie Y, Chan P, Kwan H, Chang J
J Fungi (Basel). 2023; 9(9).
PMID: 37755023
PMC: 10532568.
DOI: 10.3390/jof9090915.
N-terminal proteoforms may engage in different protein complexes.
Bogaert A, Fijalkowska D, Staes A, Van de Steene T, Vuylsteke M, Stadler C
Life Sci Alliance. 2023; 6(8).
PMID: 37316325
PMC: 10267514.
DOI: 10.26508/lsa.202301972.
A Strong Cation Exchange Chromatography Protocol for Examining N-Terminal Proteoforms.
Fernandez E, Bogaert A, Timmerman E, Staes A, Impens F, Gevaert K
Methods Mol Biol. 2022; 2477:293-309.
PMID: 35524124
DOI: 10.1007/978-1-0716-2257-5_17.
New Insights Into Pathophysiology of β-Thalassemia.
Sanchez-Villalobos M, Blanquer M, Moraleda J, Salido E, Perez-Oliva A
Front Med (Lausanne). 2022; 9:880752.
PMID: 35492364
PMC: 9041707.
DOI: 10.3389/fmed.2022.880752.
Fetal vs adult megakaryopoiesis.
Davenport P, Liu Z, Sola-Visner M
Blood. 2022; 139(22):3233-3244.
PMID: 35108353
PMC: 9164738.
DOI: 10.1182/blood.2020009301.
The Mutational Landscape of Myeloid Leukaemia in Down Syndrome.
de Castro C, Cadefau M, Cuartero S
Cancers (Basel). 2021; 13(16).
PMID: 34439298
PMC: 8394284.
DOI: 10.3390/cancers13164144.
Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Barabino S, Citterio E, Ronchi A
Cancers (Basel). 2021; 13(15).
PMID: 34359655
PMC: 8345071.
DOI: 10.3390/cancers13153753.
Changes in megakaryopoiesis over ontogeny and their implications in health and disease.
Davenport P, Liu Z, Sola-Visner M
Platelets. 2020; 31(6):692-699.
PMID: 32200697
PMC: 8006558.
DOI: 10.1080/09537104.2020.1742879.
GATA1 mutations in red cell disorders.
Ling T, Crispino J
IUBMB Life. 2019; 72(1):106-118.
PMID: 31652397
PMC: 7323890.
DOI: 10.1002/iub.2177.
The Pleiotropic Effects of GATA1 and KLF1 in Physiological Erythropoiesis and in Dyserythropoietic Disorders.
Barbarani G, Fugazza C, Strouboulis J, Ronchi A
Front Physiol. 2019; 10:91.
PMID: 30809156
PMC: 6379452.
DOI: 10.3389/fphys.2019.00091.
Congenital erythropoietic porphyria: Recent advances.
Erwin A, Desnick R
Mol Genet Metab. 2019; 128(3):288-297.
PMID: 30685241
PMC: 6597325.
DOI: 10.1016/j.ymgme.2018.12.008.
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation.
Garcia-Carpizo V, Ruiz-Llorente S, Sarmentero J, Grana-Castro O, Pisano D, Barrero M
Epigenetics Chromatin. 2018; 11(1):30.
PMID: 29884215
PMC: 5992658.
DOI: 10.1186/s13072-018-0197-x.
Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors.
Liu C, Yu T, Xing Z, Jiang X, Li Y, Pao A
Oncotarget. 2018; 9(4):4773-4786.
PMID: 29435140
PMC: 5797011.
DOI: 10.18632/oncotarget.23463.
GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
Ling T, Crispino J, Zingariello M, Martelli F, Migliaccio A
Expert Rev Hematol. 2018; 11(3):169-184.
PMID: 29400094
PMC: 6108178.
DOI: 10.1080/17474086.2018.1436965.
CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome.
Bloh K, Bialk P, Gopalakrishnapillai A, Kolb E, Kmiec E
Mol Ther Nucleic Acids. 2017; 7:288-298.
PMID: 28624204
PMC: 5415552.
DOI: 10.1016/j.omtn.2017.04.009.
Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma.
Wang L, Chen Z, Zhou W, Shu J, Wang X, Jin R
Sci Rep. 2017; 7(1):2551.
PMID: 28566697
PMC: 5451405.
DOI: 10.1038/s41598-017-02700-5.